2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

There is provided a compound of formula (1) or a pharmaceutically acceptable salt thereof (see formula 1) Also provided is the use of the compound for the treatment or prevention of a central nervous system disorder, e.g. a neurodegenerative disease, a cerebrovascular disease, seizure, epilepsy, a v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ECKLAND, DAVID JOHN AUGUSTUS, GARCIA COLLAZO, ANA MARIA, PIZCUETA LALANZA, MARIA PILAR, MARTINELL PEDEMONTE, MARC
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There is provided a compound of formula (1) or a pharmaceutically acceptable salt thereof (see formula 1) Also provided is the use of the compound for the treatment or prevention of a central nervous system disorder, e.g. a neurodegenerative disease, a cerebrovascular disease, seizure, epilepsy, a viral disease, a neuroinflammatory disease, a brain tumour, a traumatic brain injury, or a rare metabolic disease. La présente invention concerne 5-(4-(2-(5-(1-hydroxyéthyl)pyridine-2-yl)éthoxy)benzyl)thiazolidine-2,4-dione et des nouveaux stéréoisomères dudit composé à utiliser dans le traitement de troubles du système nerveux central.